Amgen Inc. Common Stock AMGN
HEALTHCARE · DRUG MANUFACTURERS - GENERALi
Market dataready · fetched 2026-11-07T05:07:08.306Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-07T00:57:05.289386245Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-07T05:07:07.803431+00:00
Amgen Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 481.49 | 37.6% | 4.9% | 443.31 | 38.9% | 4.5% |
| 25Δ | 473.86 | 29.2% | 3.2% | 447.66 | 37.3% | 3.7% |
| 30Δ | 472.24 | 32.0% | 3.1% | 450.72 | 37.8% | 3.3% |
| 35Δ | 469.54 | 32.0% | 2.7% | 454.03 | 36.5% | 2.8% |
| 40Δ | 467.13 | 32.6% | 2.4% | 456.86 | 36.3% | 2.4% |
| 45Δ | 464.55 | 31.9% | 2.0% | 459.60 | 36.3% | 2.0% |
| 50Δ | 462.21 | 32.9% | 1.8% | 462.29 | 36.2% | 1.7% |
| 55Δ | 459.77 | 33.0% | 1.5% | 464.97 | 36.0% | 1.5% |
| 60Δ | 457.49 | 31.3% | 1.2% | 468.09 | 38.2% | 1.3% |
| 65Δ | 454.77 | 32.9% | 1.1% | 470.77 | 36.6% | 1.0% |
| 70Δ | 452.57 | 31.2% | 0.8% | 474.26 | 37.8% | 0.8% |
| 75Δ | 450.34 | 29.9% | 0.6% | 477.37 | 37.0% | 0.6% |
| 80Δ | 447.73 | 29.3% | 0.5% | 482.74 | 39.9% | 0.5% |
20Δ
- Pseudo strike
- 481.49
- IV
- 37.6%
- B/E move
- 4.9%
- Pseudo strike
- 443.31
- IV
- 38.9%
- B/E move
- 4.5%
25Δ
- Pseudo strike
- 473.86
- IV
- 29.2%
- B/E move
- 3.2%
- Pseudo strike
- 447.66
- IV
- 37.3%
- B/E move
- 3.7%
30Δ
- Pseudo strike
- 472.24
- IV
- 32.0%
- B/E move
- 3.1%
- Pseudo strike
- 450.72
- IV
- 37.8%
- B/E move
- 3.3%
35Δ
- Pseudo strike
- 469.54
- IV
- 32.0%
- B/E move
- 2.7%
- Pseudo strike
- 454.03
- IV
- 36.5%
- B/E move
- 2.8%
40Δ
- Pseudo strike
- 467.13
- IV
- 32.6%
- B/E move
- 2.4%
- Pseudo strike
- 456.86
- IV
- 36.3%
- B/E move
- 2.4%
45Δ
- Pseudo strike
- 464.55
- IV
- 31.9%
- B/E move
- 2.0%
- Pseudo strike
- 459.60
- IV
- 36.3%
- B/E move
- 2.0%
50Δ
- Pseudo strike
- 462.21
- IV
- 32.9%
- B/E move
- 1.8%
- Pseudo strike
- 462.29
- IV
- 36.2%
- B/E move
- 1.7%
55Δ
- Pseudo strike
- 459.77
- IV
- 33.0%
- B/E move
- 1.5%
- Pseudo strike
- 464.97
- IV
- 36.0%
- B/E move
- 1.5%
60Δ
- Pseudo strike
- 457.49
- IV
- 31.3%
- B/E move
- 1.2%
- Pseudo strike
- 468.09
- IV
- 38.2%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 454.77
- IV
- 32.9%
- B/E move
- 1.1%
- Pseudo strike
- 470.77
- IV
- 36.6%
- B/E move
- 1.0%
70Δ
- Pseudo strike
- 452.57
- IV
- 31.2%
- B/E move
- 0.8%
- Pseudo strike
- 474.26
- IV
- 37.8%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 450.34
- IV
- 29.9%
- B/E move
- 0.6%
- Pseudo strike
- 477.37
- IV
- 37.0%
- B/E move
- 0.6%
80Δ
- Pseudo strike
- 447.73
- IV
- 29.3%
- B/E move
- 0.5%
- Pseudo strike
- 482.74
- IV
- 39.9%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 28.84% | |
| 27.94% | |
| 27.08% | |
| 26.26% | |
| 25.45% | |
| 27.25% | |
| 27.98% | |
| 33.61% | |
| 34.83% | |
| 30.44% | |
| 33.71% | |
| 33.63% | |
| 32.76% | |
| 31.70% | |
| 32.98% | |
| 34.10% | |
| 34.33% | |
| 33.99% | |
| 35.26% | |
| 33.80% | |
| 32.83% | |
| 28.76% | |
| 29.28% | |
| 24.93% | |
| 27.15% | |
| 28.03% | |
| 28.00% | |
| 27.53% | |
| 24.91% | |
| 26.83% | |
| 28.41% | |
| 29.33% | |
| 27.76% | |
| 25.42% | |
| 27.14% | |
| 27.97% | |
| 28.33% | |
| 29.62% | |
| 25.40% | |
| 27.42% | |
| 27.09% | |
| 27.20% | |
| 30.27% | |
| 28.04% | |
| 30.01% | |
| 31.24% | |
| 31.91% | |
| 30.93% | |
| 31.27% | |
| 33.42% | |
| 34.49% | |
| 34.26% | |
| 38.05% | |
| 34.08% | |
| 37.03% | |
| 35.97% | |
| 38.54% | |
| 38.29% | |
| 36.63% |
Drug Manufacturers - General
AMRN
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United…
More →AZN
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections,…
More →BIIB
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the…
More →BMY
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and…
More →GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the…
More →GRFS
Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
More →